cyclic adp-ribose has been researched along with Diabetes Mellitus, Type 2 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, K; Itaya-Hironaka, A; Makino, M; Ota, H; Sakuramoto-Tsuchida, S; Shobatake, R; Takasawa, S; Takeda, Y; Uchiyama, T; Yamauchi, A | 1 |
| Bolze, S; Fouqueray, P; Hallakou-Bozec, S; Kergoat, M; Moller, DE | 1 |
| Okamoto, H | 1 |
| Akiyama, T; Ikehata, F; Kato, I; Kobayashi, S; Nakazawa, T; Nata, K; Okamoto, H; Satoh, J; Takasawa, S; Tohgo, A; Toyota, T | 1 |
| Kato, I; Nata, K; Noguchi, N; Okamoto, H; Takasawa, S; Tohgo, A | 1 |
2 review(s) available for cyclic adp-ribose and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
New aspects to the functioning and regeneration of pancreatic beta-cells. Cyclic ADP-ribose and Reg gene.
Topics: Adenosine Diphosphate Ribose; ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Animals; Antigens, CD; Antigens, Differentiation; Calcium-Binding Proteins; Cell Division; Cyclic ADP-Ribose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Islets of Langerhans; Lithostathine; Membrane Glycoproteins; Models, Biological; NAD+ Nucleosidase; Nerve Tissue Proteins; Phosphoproteins; Second Messenger Systems | 1997 |
Physiological and pathological significance of the CD38-cyclic ADP-ribose signaling system.
Topics: Adenosine Diphosphate Ribose; ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Amino Acid Sequence; Animals; Antigens, CD; Antigens, Differentiation; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cyclic ADP-Ribose; Diabetes Mellitus, Type 2; Glucose; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Membrane Glycoproteins; Molecular Sequence Data; Multienzyme Complexes; NAD; NAD+ Nucleosidase | 2000 |
3 other study(ies) available for cyclic adp-ribose and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Downregulation of the Cd38-Cyclic ADP-Ribose Signaling in Cardiomyocytes by Intermittent Hypoxia via Pten Upregulation.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Animals; Calcium Signaling; Cardiovascular Diseases; Cyclic ADP-Ribose; Diabetes Mellitus, Type 2; Down-Regulation; Hypoxia; Membrane Glycoproteins; Mice; Myocytes, Cardiac; PTEN Phosphohydrolase; Rats; RNA, Messenger; Ryanodine Receptor Calcium Release Channel; Up-Regulation | 2022 |
Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action.
Topics: Adenosine Triphosphate; Animals; Calcium; Cyclic ADP-Ribose; Cytokines; Diabetes Mellitus, Type 2; Glucose; Insulin Secretion; Islets of Langerhans; Male; Models, Biological; NAD; Niacinamide; Nicotinamide Phosphoribosyltransferase; Rats, Wistar; Ryanodine Receptor Calcium Release Channel; Sulfonylurea Compounds; Triazines | 2021 |
Autoantibodies against CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) that impair glucose-induced insulin secretion in noninsulin- dependent diabetes patients.
Topics: Adenosine Diphosphate Ribose; ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Adult; Aged; Aged, 80 and over; Animals; Antigens, CD; Antigens, Differentiation; Autoantibodies; Cyclic ADP-Ribose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucose; Humans; Insulin; Insulin Secretion; Male; Membrane Glycoproteins; Middle Aged; NAD+ Nucleosidase; Rats; Rats, Wistar | 1998 |